UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.039

Sortiert nach

Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge

European journal of cancer (1990), 2013-07, Vol.49 (10), p.2311-2320

2013

Volltextzugriff (PDF)

Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study

Annals of surgical oncology, 2017-09, Vol.24 (9), p.2632-2638

2017

Volltextzugriff (PDF)

HLA-matched allo-SCT after reduced intensity conditioning with fludarabine CY in patients with metastatic breast cancer

Bone marrow transplantation (Basingstoke), 2010-03, Vol.45 (3), p.464-467

2010

Volltextzugriff (PDF)

The unknown biology of the unknown primary tumour: a literature review

Annals of oncology, 2003-02, Vol.14 (2), p.191-196

2003

Volltextzugriff (PDF)

Immunochemotherapy with interleukin-2, interferon-α and 5-fluorouracil for progressive metastatic renal cell carcinoma : a multicenter phase II study

British journal of cancer, 2000-02, Vol.82 (4), p.772-776

2000

Volltextzugriff (PDF)

Primary monophasic mediastinal, cardiac and pericardial synovial sarcoma: a young man in distress

Netherlands heart journal, 2007-06, Vol.15 (6), p.226-228

2007

Volltextzugriff (PDF)

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group

European journal of cancer (1990), 2003-02, Vol.39 (3), p.346-352

2003

Volltextzugriff (PDF)

Clinical relevance of apoptotic markers in breast cancer not yet clear

Apoptosis (London), 2002-08, Vol.7 (4), p.361-365

2002

Volltextzugriff (PDF)

CD44v6 is not a prognostic factor in primary breast cancer

Annals of oncology, 1998-01, Vol.9 (1), p.109-111

1998

Volltextzugriff (PDF)

MIB-1 labelling index is an independent prognostic marker in primary breast cancer

British journal of cancer, 1998-08, Vol.78 (4), p.460-465

1998

Volltextzugriff (PDF)

Non-myeloablative transplantation for solid tumors. Still a long way to go?

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6629-6629

2004

Volltextzugriff (PDF)

Non-myeloablative transplantation for solid tumors. Still a long way to go?

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.6629-6629

2004

Volltextzugriff (PDF)

Phase III trial of carboplatin, etoposide and paclitaxel compared with 5-fluorouracil and folinic acid in adenocarcinoma of unknown primary

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.9681-9681

2005

Volltextzugriff (PDF)

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer

Anticancer research, 1998-11, Vol.18 (6A), p.4455

1998

Volltextzugriff (PDF)

Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus

Nederlands tijdschrift voor geneeskunde, 2008-02, Vol.152 (7), p.371

2008

Volltextzugriff (PDF)

Interleukin-2 and interferon-alpha in the treatment of patients with advanced non-small-cell lung cancer

Journal of immunotherapy, 1992-07, Vol.12 (1), p.70

1992

Volltextzugriff (PDF)

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon α for metastatic melanoma: a multicentre phase II study

British journal of cancer, 1997, Vol.76 (2), p.266-269

1997

Volltextzugriff (PDF)

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas

European journal of cancer (1990), 1998-09, Vol.34 (10), p.1570-1574

1998

Volltextzugriff (PDF)

pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer

Anticancer research, 1998-01, Vol.18 (1B), p.577

1998

Volltextzugriff (PDF)

High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes

Bone marrow transplantation (Basingstoke), 1998-02, Vol.21 (3), p.243-247

1998

Volltextzugriff (PDF)

Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response

Journal of clinical oncology, 1993-05, Vol.11 (5), p.921-924

1993

Volltextzugriff (PDF)

Immunochemotherapy with interleukin-2, interferon- and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study

British journal of cancer, 2000-02, Vol.82 (4), p.772-776

2000

Volltextzugriff (PDF)

Xanthogranulomatous Pyelonephritis: A Pseudo-Neoplastic Disease

Acta oncologica, 1999, Vol.38 (2), p.269-271

1999

Volltextzugriff (PDF)

Repetitive weekly cycles of 4-day continuous infusion of recombinant interleukin-2: a phase I study

Journal of immunotherapy, 1992-11, Vol.12 (4), p.277

1992

Volltextzugriff (PDF)

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Annals of oncology, 2019-07, Vol.30 (7), p.1154-1161

2019

Volltextzugriff (PDF)

1 – 25 von 2.039

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.867)
Mit Volltextzugriff
(1.794)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Physics Letters. B
(32)
Physical Review Letters
(25)
Blood
(23)
Stroke
(21)
The Lancet
(18)
Nuclear Physics. B
(17)
The New England Journal Of Medicine
(17)
Zeitschrift Für Physik. C, Particles And Fields
(17)
Physica Status Solidi. C
(15)
British Journal Of Surgery
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge

Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study

HLA-matched allo-SCT after reduced intensity conditioning with fludarabine CY in patients with metastatic breast cancer

The unknown biology of the unknown primary tumour: a literature review

Immunochemotherapy with interleukin-2, interferon-α and 5-fluorouracil for progressive metastatic renal cell carcinoma : a multicenter phase II study

Primary monophasic mediastinal, cardiac and pericardial synovial sarcoma: a young man in distress

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group

Clinical relevance of apoptotic markers in breast cancer not yet clear

CD44v6 is not a prognostic factor in primary breast cancer

MIB-1 labelling index is an independent prognostic marker in primary breast cancer

Non-myeloablative transplantation for solid tumors. Still a long way to go?

Non-myeloablative transplantation for solid tumors. Still a long way to go?

Phase III trial of carboplatin, etoposide and paclitaxel compared with 5-fluorouracil and folinic acid in adenocarcinoma of unknown primary

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer

Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus

Interleukin-2 and interferon-alpha in the treatment of patients with advanced non-small-cell lung cancer

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon α for metastatic melanoma: a multicentre phase II study

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas

pS2 is an independent prognostic factor for post-relapse survival in primary breast cancer

High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes

Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response

Immunochemotherapy with interleukin-2, interferon- and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study

Xanthogranulomatous Pyelonephritis: A Pseudo-Neoplastic Disease

Repetitive weekly cycles of 4-day continuous infusion of recombinant interleukin-2: a phase I study

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Suchergebnisse filtern